THE 4WARD COALITION Trademark

Trademark Overview

On Tuesday, June 30, 2015, a trademark application was filed for THE 4WARD COALITION with the United States Patent and Trademark Office. The USPTO has given the THE 4WARD COALITION trademark a serial number of 86679365. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 3, 2024. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The THE 4WARD COALITION trademark is filed in the Education & Entertainment Services category with the following description:

Providing educational services in the nature of conducting classes, seminars, conferences, workshops and webinars in the field of health management and treatment of disease states, particularly with respect to anticoagulant therapy in non-valvular atrial fibrillation
the 4ward coalition

General Information

Serial Number86679365
Word MarkTHE 4WARD COALITION
Filing DateTuesday, June 30, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 3, 2024
Registration Number5311872
Registration DateTuesday, October 17, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements

Goods and ServicesProviding educational services in the nature of conducting classes, seminars, conferences, workshops and webinars in the field of health management and treatment of disease states, particularly with respect to anticoagulant therapy in non-valvular atrial fibrillation
Pseudo MarkTHE FORWARD COALITION
NOT AVAILABLE"COALITION"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 3, 2024
Primary Code041
First Use Anywhere DateThursday, March 31, 2016
First Use In Commerce DateThursday, March 31, 2016

Trademark Owner History

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877
Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877
Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events

Event DateEvent Description
Tuesday, July 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 3, 2015NEW APPLICATION ENTERED
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 8, 2015NOTICE OF PSEUDO MARK E-MAILED
Tuesday, August 11, 2015ASSIGNED TO EXAMINER
Wednesday, August 19, 2015NON-FINAL ACTION WRITTEN
Wednesday, August 19, 2015NON-FINAL ACTION E-MAILED
Wednesday, August 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 16, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 17, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 19, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 23, 2016TEAS STATEMENT OF USE RECEIVED
Wednesday, November 23, 2016USE AMENDMENT FILED
Tuesday, December 13, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 19, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, December 19, 2016SU - NON-FINAL ACTION - WRITTEN
Monday, December 19, 2016NON-FINAL ACTION E-MAILED
Monday, June 19, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 8, 2017ASSIGNED TO LIE
Friday, September 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 20, 2017SU - FINAL REFUSAL - WRITTEN
Tuesday, June 20, 2017FINAL REFUSAL E-MAILED
Tuesday, June 20, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, August 27, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, September 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 14, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 15, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 17, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 3, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

coalition ward particularly states disease treatment respect anticoagulant fibrillation atrial valvular therapy